null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222097

Enrollment

650

Registered

2013-06-03

Start date

2013-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : Amikacin Therapeutic category code : 612 Antibiotic preparations acting mainly on gram-positive bacteria Dosage and Ad

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
efficacy pharmacokinetics safety pharmacodynamics	—

Countries

Asia except Japan, Europe, Japan

Outcome results